Medications for Lung Cancer

Lung cancer comprises two main types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

NSCLC is the most prevalent form, making up roughly 85% of all lung cancer cases. It comprises different subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma, often linked to non-smokers, forms in the outer lung regions, while squamous cell carcinoma, associated with smokers, starts in the central airways. Large cell carcinoma, less common but aggressive, can develop anywhere in the lungs.

NSCLC typically presents later, but advances in targeted therapies and immunotherapy offer promising treatments, focusing on specific genetic mutations, or harnessing the immune system. For medications used to treat NSCLC, click here.

SCLC constitutes about 15% of lung cancer cases. Known for its rapid growth and early metastasis, it primarily affects heavy smokers. Due to its aggressive nature, surgical options are limited. The mainstay of treatment for SCLC is intensive chemotherapy, often combined with radiation therapy. For medications used to treat SCLC, click here.